RWS
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Real World Study of Pyrotinib in the Treatment of Advanced Breast Cancer With HER2 Positive (NCT06495541) | Tianjin Medical University Cancer Institute and Hospital | 2026-04-01 |
| A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer (NCT06485271) | Changzhi People's Hospital Affiliated to Changzhi Medical College | 2023-11-01 |
Track RWS automatically
Every clearance here is in the API, with alerts when new ones post.